During the past decade, CHP Beauregard conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHP Beauregard" #1 sponsor was "LivaNova" with 3 trials, followed by "Biosensors Europe SA" with 1 trials sponsored, "European Cardiovascular Research Center" with 1 trials sponsored, "French Cardiology Society" with 1 trials sponsored and "Hexacath, France" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "CHP Beauregard" are "Acute Coronary Syndrome" (1 trials), "Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients." (1 trials), "Atrial Fibrillation, Persistent" (1 trials), "Biventricular Tachycardias" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "CHP Beauregard" in a lesser frequency.

Most popular intervention types in "CHP Beauregard" are "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ablation by radiofrequency of low-voltage areas" (1 trials), "Angioplasty (PROMUS Element™, and Xience™ Prime stent)" (1 trials), "Cardiac Resynchronization Therapy -Defibrillator (range PARADYM, LivaNova, Clamart, France)" (1 trials), "Cobalt-Chromium Bare Metal Stents" (1 trials) and "Isolation of pulmonary veins" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHP Beauregard" are 8 trials for "All" genders.

Currently, there are NaN active trials in "CHP Beauregard". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHP Beauregard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHP Beauregard, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".